AMERICAN HOME PRODUCTS CORPORATION

Link copied
Case Copied 41 min read

official notice

decision of a delegate of the commissioner of patents

Application        : No. 16397/92 in the name of AMERICAN HOME PRODUCTS CORPORATION

Title: Process and intermediates for making isoquinoline derivatives

Action: Hearing in relation to objections during examination

Decision: Issued            .

Abstract: Requirements for novelty and inventive step of compounds per se discussed.

Novelty of compounds assessed by considering:
-  was the citation published before the priority date of the application under examination;
-  what are the essential features of the invention as claimed;
-  what is disclosed by the citation (what is clearly and unmistakably disclosed, and does the disclosure enable the preparation of the compounds);  and
-  is the application a selection?

Claims to intermediate compounds found to possess an inventive step but to be not novel.

patents act 1990

decision of a delegate of the commissioner of patents

Re:Patent Application No. 16397/92 by American Home Products Corporation, and objections raised by the Commissioner during examination.

background

Patent application 16397/92, which is entitled "Process and intermediates for making isoquinoline derivatives" was filed on 20 May 1992.  The applicant and nominated person is American Home Products Corporation.  The application claims priority from a United States application (having a priority date of 22 May 1991) and a United Kingdom application (having a priority date of 8 April 1992).

A first examination report, raising only the issue of novelty, was issued on 2 August 1993.  This objection was maintained in the light of argument from the patent attorney for the applicant.  After the third adverse report, the applicant requested a hearing.  The applicant was then notified (in a fourth adverse report) that there was also an inventive step objection.

The hearing was held in Canberra on 1 July 1994.  The applicant was represented by Mr Paul Kilborn (patent attorney of Phillips Ormonde & Fitzpatrick, Melbourne).

the specification

The specification commences with the statement:

"The present invention relates to a process for the preparation of spiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones which are useful as aldose reductase inhibitors.  The invention also relates to novel intermediates useful in the process."

The admitted prior art reveals that spiro-isoquinoline­pyrrolidines are known to be useful as aldose reductase inhibitors.  The problem addressed by the specification is to improve the yield for the preparation of spiro-isoquinoline-pyrrolidines.

The specification relates specifically to a process for the preparation of compounds having the formula:

(II)

in which R1 is hydrogen or halogen and R2 is methyl or dihalogen-substituted benzyl.

The compounds of formula (II) are prepared by the following process:

The specification ends with 15 claims.  The key claim is claim 10, which reads as follows:

"10.A nitrile having the formula

(IV)

wherein R1, R2 and -CO2R3 are as defined in claim 1."

The variables R1, R2 and -CO2R3 are defined in claim 1 in the following terms:  "R1 is hydrogen or halogen and R2 is methyl or dihalogen-substituted benzyl", and "-CO2R3 is an ester group".

Claims 11, 12, and 15 are appended to claim 10.  They read as follows:

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read AMERICAN HOME PRODUCTS CORPORATION and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[1994] APO 58
Decision Date

CaseChat Overview and Summary

The delegate of the Commissioner of Patents was required to determine whether a patent application for a process and intermediates for making isoquinoline derivatives was novel and involved an inventive step. The application was opposed by the Commissioner on the grounds that it was not novel and did not involve an inventive step. The applicant, American Home Products Corporation, argued that the compounds in question were novel and involved an inventive step. The delegate found that while the compounds in question possessed an inventive step, they were not novel. The decision was based on the analysis of the essential features of the invention, the degree of disclosure required for anticipation, and the problem-solution approach to assessing inventive step. The delegate concluded that the invention defined by claim 10 (and also claims 11, 12, and 15) possessed an inventive step but was not novel when compared to the disclosure of AU 617541. The deficiency could be overcome by amendment, and the applicant was granted time to propose amendments.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.